Fangzhou Jianke Group Honored as One of China's Top 10 Pandemic-Fighting Internet Healthcare Service Platforms

On April 28, the 13th Healthy China Forum was held in Beijing, with this year’s theme being “New Opportunities、New Business Models、New TrendsCentered on the theme, with special attention to major strategic issues under the “14th Five-Year Plan” and the Healthy China Action, the discussion focused on the construction of public health systems amid COVID-19 prevention and control, as well as the establishment of systems for responding to major public health emergencies. Notably, during the event, the organizers conducted an awards ceremony, in which Fangzhou Jianke Group, a leading smart health service platform in China, was honored as one of the Top Ten Internet Medical and Health Service Enterprises for Anti-Epidemic Efforts of the Year.

It is reported that this event, co-hosted by the Health Client of People’s Daily and Health Times, has been held for 12 editions. Over the past 12 years, evolving from “Building a Healthy China” to the “Healthy China Strategy,” and further to the “Healthy China Action,” the Healthy China Forum has become one of the earliest-established, most influential, highest-quality, and most authoritative conferences among those themed around “Healthy China” in China’s pharmaceutical, healthcare, and public health sectors. It has grown into a national high-level forum with the participation of Party committees and governments at all levels, competent authorities, as well as professionals from the medical, health insurance, pharmaceutical, healthcare, and media sectors.

At the forum held that day, key officials from the National Health Commission, the National Healthcare Security Administration, and the National Medical Products Administration were in attendance. They focused on major strategic issues related to the 14th Five-Year Plan and the Healthy China Initiative, and provided interpretations of significant policies such as national reimbursement drug list negotiations, volume-based procurement, and internet healthcare.

At the 13th Healthy China-Watson Grand Health Night, the organizers also presented a series of awards, including the Top Ten Pharmaceutical Industry Figures (Domestic and Foreign), Top Ten New Drugs (Domestic and International), Top Ten Health Industry Figures, Top Ten Internet Hospitals, and Top Ten Health and Elderly Care Projects of the 13th Healthy China Forum. It was reported that the list was compiled based on the principles of “media perspective, social responsibility, and health promotion,” and evaluated against three major criteria: technological innovation, industry status, and social reputation. Through recommendations from industry experts, peer interviews, and data verification, all conducted on a voluntary basis, an initial shortlist—including the Top Ten Anti-Epidemic Internet Service Platforms—was formed. The Organizing Committee invited 50 experts and scholars from policy-making bodies, research institutes, and professional associations in fields such as the pharmaceutical industry, internet healthcare, and the aging industry to constitute the Advisory Committee for the 13th Healthy China Forum Rankings. Based on the initial shortlist, extensive opinions were solicited from the advisory committee members to finalize the selected list.

Fangzhou Jianke Group (Guangzhou Fangzhou Pharmaceutical Co., Ltd.) leveraged the unique advantages of internet hospitals and online medical consultations in 2020 by supplying epidemic prevention materials, providing medication services, and facilitating online prescription renewals. The company made significant contributions to epidemic prevention and control, successfully navigating the major challenge of combating the pandemic, and was honored as one of the “Top Ten Internet Healthcare Service Enterprises for Epidemic Response” of the year.

It is reported that since January 2020, Fangzhou Jianke Group has made multiple donations of anti-epidemic supplies and funds to support medical personnel fighting the pandemic in Wuhan, as well as enterprises and institutions across Guangdong and Xinjiang resuming work and production. In addition, in response to the national call to decisively win the battle against epidemic prevention and control, and to the initiative of “fully leveraging information platforms to provide online consultation services,” the company immediately announced that it would remain open without interruption, sparing no effort to ensure the market supply of anti-epidemic materials. During the Spring Festival holiday, it launched services such as online follow-up consultations, prescription renewals, and home delivery of medications, further safeguarding the medication needs of patients with chronic diseases during the outbreak. These efforts demonstrated the value and appeal of internet-based healthcare in the fight against the epidemic.